JP2005530779A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530779A5 JP2005530779A5 JP2004505028A JP2004505028A JP2005530779A5 JP 2005530779 A5 JP2005530779 A5 JP 2005530779A5 JP 2004505028 A JP2004505028 A JP 2004505028A JP 2004505028 A JP2004505028 A JP 2004505028A JP 2005530779 A5 JP2005530779 A5 JP 2005530779A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- use according
- alkyl
- functional gastrointestinal
- gastrointestinal disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims 19
- 125000000217 alkyl group Chemical group 0.000 claims 11
- 208000014540 Functional gastrointestinal disease Diseases 0.000 claims 9
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- -1 amino Chemical group 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000002496 gastric effect Effects 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 208000012661 Dyskinesia Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000005615 Interstitial Cystitis Diseases 0.000 claims 1
- 206010062501 Non-cardiac chest pain Diseases 0.000 claims 1
- KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 claims 1
- 208000000450 Pelvic Pain Diseases 0.000 claims 1
- JLESPOKBPILILK-UHFFFAOYSA-N [O-][N+](=O)[C]C#N Chemical group [O-][N+](=O)[C]C#N JLESPOKBPILILK-UHFFFAOYSA-N 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 210000000013 bile duct Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000005070 sphincter Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38130502P | 2002-05-17 | 2002-05-17 | |
| PCT/US2003/015230 WO2003097029A1 (en) | 2002-05-17 | 2003-05-15 | Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530779A JP2005530779A (ja) | 2005-10-13 |
| JP2005530779A5 true JP2005530779A5 (enExample) | 2006-06-29 |
Family
ID=29550101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004505028A Pending JP2005530779A (ja) | 2002-05-17 | 2003-05-15 | ベンラファキシンとその誘導体を用いた胃腸または尿生殖器痛障害の治療方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040019101A1 (enExample) |
| EP (1) | EP1505960A1 (enExample) |
| JP (1) | JP2005530779A (enExample) |
| KR (1) | KR20050003464A (enExample) |
| CN (1) | CN1652758A (enExample) |
| AR (1) | AR040033A1 (enExample) |
| AU (1) | AU2003232137A1 (enExample) |
| BR (1) | BR0310083A (enExample) |
| CA (1) | CA2485736A1 (enExample) |
| CR (1) | CR7568A (enExample) |
| EC (1) | ECSP045436A (enExample) |
| IL (1) | IL165216A0 (enExample) |
| MX (1) | MXPA04011329A (enExample) |
| NO (1) | NO20044868L (enExample) |
| NZ (1) | NZ548950A (enExample) |
| RU (1) | RU2004136999A (enExample) |
| SG (1) | SG165991A1 (enExample) |
| TW (1) | TW200402289A (enExample) |
| UA (1) | UA81413C2 (enExample) |
| WO (1) | WO2003097029A1 (enExample) |
| ZA (1) | ZA200410157B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491723B2 (en) * | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
| US7419980B2 (en) * | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
| US7365076B2 (en) | 2003-10-14 | 2008-04-29 | Wyeth | Substituted aryl cycloalkanol derivatives and methods of their use |
| US7550485B2 (en) * | 2003-10-14 | 2009-06-23 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
| US7524846B2 (en) * | 2003-10-14 | 2009-04-28 | Wyeth | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| US7402698B2 (en) * | 2003-10-14 | 2008-07-22 | Wyeth | Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use |
| US7531543B2 (en) * | 2003-10-14 | 2009-05-12 | Wyeth | Phenylpiperazine cycloalkanol derivatives and methods of their use |
| US20060148781A1 (en) * | 2003-11-10 | 2006-07-06 | Lundeen James E | Method and medicine for treating gastrointestinal disorder in a non-human mammal |
| US20050113365A1 (en) * | 2003-11-10 | 2005-05-26 | Sir Isaac Newton Enterprises Llc | Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome |
| US20060148783A1 (en) * | 2003-11-10 | 2006-07-06 | Lundeen James E | Method and medicine for treating gastrointestinal disorder including fecal incontinence |
| US20070142367A1 (en) * | 2003-11-10 | 2007-06-21 | Lundeen James E | Method and medicine for treating gastrointestinal disorder including fecal incontinence |
| US20060148782A1 (en) * | 2003-11-10 | 2006-07-06 | Lundeen James E | Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both |
| US7820690B2 (en) * | 2004-03-19 | 2010-10-26 | Solvay Pharmaceuticals Gmbh | Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist |
| US7517899B2 (en) * | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7414052B2 (en) * | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
| GB201007032D0 (en) * | 2010-04-27 | 2010-06-09 | Dormer Tools Ltd | Twist drill for advanced materials |
| CN102095461B (zh) * | 2011-01-18 | 2012-07-18 | 姚贤卿 | 复合型干度质量流量仪及干度标定测量方法 |
| RU2740750C1 (ru) * | 2020-03-27 | 2021-01-20 | Аллан Герович Бениашвили | Средство для лечения функциональных заболеваний желудочно-кишечного тракта |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| US5990159A (en) * | 1996-02-15 | 1999-11-23 | Janssen Pharmaceutica, N.V. | Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| US6579899B1 (en) * | 1998-07-16 | 2003-06-17 | Massachusetts Institute Of Technology | Composition for treatment of stress |
| JP2002530341A (ja) * | 1998-11-23 | 2002-09-17 | セプラコール， インク． | デスメチルオランザピン組成物及び方法 |
| CA2352611A1 (en) * | 1998-11-23 | 2000-06-02 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| CA2351719A1 (en) * | 1998-11-23 | 2000-06-02 | Sepracor Inc. | Pharmaceutical compositions containing olanzapine-n-oxide |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| GB2355191A (en) * | 1999-10-12 | 2001-04-18 | Laxdale Ltd | Combination formulations for fatigue, head injury and strokes |
| MXPA04011529A (es) * | 2002-04-24 | 2005-08-15 | Cypress Bioscience Inc | Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension. |
| NZ537142A (en) * | 2002-06-10 | 2008-01-31 | Wyeth Corp | Novel formate salt of O-desmethyl-venlafaxine |
-
2003
- 2003-05-14 TW TW092113062A patent/TW200402289A/zh unknown
- 2003-05-15 IL IL16521603A patent/IL165216A0/xx unknown
- 2003-05-15 KR KR10-2004-7018585A patent/KR20050003464A/ko not_active Abandoned
- 2003-05-15 WO PCT/US2003/015230 patent/WO2003097029A1/en not_active Ceased
- 2003-05-15 US US10/438,572 patent/US20040019101A1/en not_active Abandoned
- 2003-05-15 BR BR0310083-9A patent/BR0310083A/pt not_active IP Right Cessation
- 2003-05-15 RU RU2004136999/14A patent/RU2004136999A/ru unknown
- 2003-05-15 UA UA20041210379A patent/UA81413C2/xx unknown
- 2003-05-15 MX MXPA04011329A patent/MXPA04011329A/es unknown
- 2003-05-15 JP JP2004505028A patent/JP2005530779A/ja active Pending
- 2003-05-15 NZ NZ548950A patent/NZ548950A/en unknown
- 2003-05-15 AU AU2003232137A patent/AU2003232137A1/en not_active Withdrawn
- 2003-05-15 EP EP03753036A patent/EP1505960A1/en not_active Withdrawn
- 2003-05-15 SG SG200607202-9A patent/SG165991A1/en unknown
- 2003-05-15 CA CA002485736A patent/CA2485736A1/en not_active Abandoned
- 2003-05-15 CN CNA038112612A patent/CN1652758A/zh active Pending
- 2003-05-16 AR ARP030101715A patent/AR040033A1/es unknown
-
2004
- 2004-11-04 CR CR7568A patent/CR7568A/es not_active Application Discontinuation
- 2004-11-09 NO NO20044868A patent/NO20044868L/no not_active Application Discontinuation
- 2004-11-17 EC EC2004005436A patent/ECSP045436A/es unknown
- 2004-12-15 ZA ZA200410157A patent/ZA200410157B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005530779A5 (enExample) | ||
| RU2004136999A (ru) | Способы лечения болевых расстройств желудочно-кишечной и мочеполовой систем, использующие венлфаксин и его производные | |
| JP2003532731A5 (enExample) | ||
| JP2005511698A5 (enExample) | ||
| JP2007508361A5 (enExample) | ||
| JP2004507465A5 (enExample) | ||
| CA2405796A1 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
| JP2011527333A5 (enExample) | ||
| JP2005505506A5 (enExample) | ||
| JPWO2020123827A5 (enExample) | ||
| JP2007538094A5 (enExample) | ||
| JP2010530881A5 (enExample) | ||
| JP2007511504A5 (enExample) | ||
| JP2004514663A5 (enExample) | ||
| JP2008513498A5 (enExample) | ||
| JP2009538873A5 (enExample) | ||
| JP2011505356A5 (enExample) | ||
| JP2002518502A5 (enExample) | ||
| JP2003530433A5 (enExample) | ||
| JP2013522368A5 (enExample) | ||
| JP2002527414A5 (enExample) | ||
| JP2010505865A5 (enExample) | ||
| JP2004525184A5 (enExample) | ||
| JP2004533415A5 (enExample) | ||
| JP2007532649A5 (enExample) |